Correction: Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”. <i>J. Clin. Med.</i> 2019, <i>8</i>, 1066

by Domenico Russo, Rocco Tripepi, Fabio Malberti, Biagio Di Iorio, Bernadette Scognamiglio, Luca Di Lullo, Immacolata Gaia Paduano, Giovanni Luigi Tripepi, Vincenzo Antonio Panuccio
Published 2020-04-01

Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”

by Domenico Russo, Rocco Tripepi, Fabio Malberti, Biagio Di Iorio, Bernadette Scognamiglio, Luca Di Lullo, Immacolata Gaia Paduano, Giovanni Luigi Tripepi, Vincenzo Antonio Panuccio
Published 2019-07-01

Oxidative Stress as Estimated by Gamma-Glutamyl Transferase Levels Amplifies the Alkaline Phosphatase-Dependent Risk for Mortality in ESKD Patients on Dialysis

by Claudia Torino, Francesco Mattace-Raso, Jan L. C. M. van Saase, Maurizio Postorino, Giovanni Luigi Tripepi, Francesca Mallamaci, Carmine Zoccali, PROGREDIRE Study Group
Published 2016-01-01